Effect of alpha-interferon on natural killer cell activity and lymphocyte subsets in thalassemia patients with chronic hepatitis C

被引:0
|
作者
Malaponte, G
Passero, E
Leonardi, S
Monte, V
Lauria, C
Mazzarino, C
Sciotto, A
Mancuso, GR
DiGregorio, F
Musumeci, S
机构
[1] CATANIA UNIV, INST GEN PATHOL, CATANIA, ITALY
[2] CATANIA UNIV, DEPT PAEDIAT, CATANIA, ITALY
[3] CATANIA UNIV, DIV PAEDIAT HAEMATOL ONCOL, CATANIA, ITALY
关键词
NK cells; lymphocyte subsets; thalassemia major; hepatitis C; alpha-interferon;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The variation of natural killer (NK) cell activity and lymphocyte subsets 20 h after a single test dose of alpha-IFN, was studied in 17 thalassemic patients with chronic hepatitis C. All patients had suspended the alpha-IFN therapy at least 12 months before the study: 10 were considered responders and 7 nonresponders. Also NK cell cytotoxicity after in vitro incubation with alpha-IFN was studied. The administration of a single dose of alpha-IFN increased NK cell cytotoxic activity significantly in the group of responders and in non-responders; moreover the NK cell cytotoxic activity after alpha-IFN in vitro incubation increased both in responders and nonresponders, but to a lesser degree than in healthy controls. Absolute values of CD4+ and CD8+ lymphocytes decreased significantly only in responders. In conclusion, our data suggest that the variation of NK cytotoxic activity and lymphocyte subsets after a test dose of alpha-IFN can be considered a parameter related to IFN biological effects.
引用
收藏
页码:83 / 88
页数:6
相关论文
共 50 条
  • [21] TREATMENT OF CHRONIC HEPATITIS-C WITH ALPHA-INTERFERON
    FARRELL, GC
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1991, 6 : 36 - 40
  • [22] ALPHA-INTERFERON TREATMENT OF CHRONIC HEPATITIS-C
    ROMEO, R
    RUMI, M
    COLOMBO, M
    BIOMEDICINE & PHARMACOTHERAPY, 1995, 49 (03) : 111 - 115
  • [23] PERIPHERAL-BLOOD LYMPHOCYTE SUBSETS AND NATURAL-KILLER CELL NUMBER AND FUNCTION DURING ALPHA-INTERFERON TREATMENT FOR HAIRY-CELL LEUKEMIA
    GIBSON, J
    GALLAGHER, K
    CAMERON, K
    BASTEN, A
    GATENBY, P
    JOSHUA, D
    KRONENBERG, H
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1988, 18 (07): : 897 - 899
  • [24] EFFECT OF ALPHA-INTERFERON ON HEPATITIS-C VIRUS CHRONIC INFECTION IN MIXED CRYOGLOBULINEMIA PATIENTS
    FERRI, C
    ZIGNEGO, AL
    LONGOMBARDO, G
    MONTI, M
    LACIVITA, L
    LOMBARDINI, F
    GRECO, F
    MAZZONI, A
    PASERO, G
    GENTILINI, P
    BOMBARDIERI, S
    MANNS, M
    INFECTION, 1993, 21 (02) : 93 - 97
  • [25] PSORIASIS IS NOT A CONTRAINDICATION FOR ALPHA-INTERFERON TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS-C
    RAHAMIMOV, R
    KLAUS, S
    TURKASPA, R
    ACTA DERMATO-VENEREOLOGICA, 1995, 75 (01) : 86 - 86
  • [26] ALPHA-INTERFERON THERAPY IN HBSAG POSITIVE PATIENTS WITH CHRONIC HEPATITIS-C
    GEHENOT, M
    MARCELLIN, P
    COLIN, JF
    MARTINOT, M
    BENHAMOU, JP
    ERLINGER, S
    HEPATOLOGY, 1995, 22 (04) : 38 - 38
  • [27] PHLEBOTOMY FOLLOWED BY ALPHA-INTERFERON THERAPY IN PATIENTS WITH CHRONIC HEPATITIS-C
    YANO, M
    KAKUMU, S
    HAYASHI, H
    TAKIKAWA, T
    NISHIMURA, N
    HEPATOLOGY, 1995, 22 (04) : 51 - 51
  • [28] TREATMENT OF RELAPSES IN PATIENTS WITH CHRONIC HEPATITIS-C WITH RECOMBINANT ALPHA-INTERFERON
    BRESCI, G
    PARISI, G
    BANTI, S
    BERTONI, M
    CAPRIA, A
    CLINICAL DRUG INVESTIGATION, 1995, 10 (04) : 215 - 220
  • [29] NATURAL-KILLER CELL-ACTIVITY IN PATIENTS WITH MULTIPLE-SCLEROSIS GIVEN HUMAN ALPHA-INTERFERON
    RICE, GPA
    CASALI, P
    MERIGAN, T
    OLDSTONE, MBA
    FEDERATION PROCEEDINGS, 1983, 42 (05) : 1216 - 1216
  • [30] Acute hepatitis induced by alpha-interferon in a patient with chronic hepatitis C
    Kraus, I
    Vitezic, D
    CANADIAN JOURNAL OF GASTROENTEROLOGY, 2001, 15 (05): : 333 - 335